BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37683712)

  • 1. Altered splicing factor and alternative splicing events in a mouse model of diet- and polychlorinated biphenyl-induced liver disease.
    Petri BJ; Piell KM; Wahlang B; Head KZ; Rouchka EC; Park JW; Hwang JY; Banerjee M; Cave MC; Klinge CM
    Environ Toxicol Pharmacol; 2023 Oct; 103():104260. PubMed ID: 37683712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polychlorinated biphenyls alter hepatic m6A mRNA methylation in a mouse model of environmental liver disease.
    Petri BJ; Piell KM; Wahlang B; Head KZ; Andreeva K; Rouchka EC; Cave MC; Klinge CM
    Environ Res; 2023 Jan; 216(Pt 3):114686. PubMed ID: 36341798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiomics analysis of the impact of polychlorinated biphenyls on environmental liver disease in a mouse model.
    Petri BJ; Piell KM; Wahlang B; Head KZ; Andreeva K; Rouchka EC; Pan J; Rai SN; Cave MC; Klinge CM
    Environ Toxicol Pharmacol; 2022 Aug; 94():103928. PubMed ID: 35803474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity.
    Jin J; Wahlang B; Shi H; Hardesty JE; Falkner KC; Head KZ; Srivastava S; Merchant ML; Rai SN; Cave MC; Prough RA
    Med Chem Res; 2020 Jul; 29():1247-1263. PubMed ID: 32831531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant FGF21 Attenuates Polychlorinated Biphenyl-Induced NAFLD/NASH by Modulating Hepatic Lipocalin-2 Expression.
    Kim HY; Yoo YH
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polychlorinated biphenyls altered gut microbiome in CAR and PXR knockout mice exhibiting toxicant-associated steatohepatitis.
    Wahlang B; Alexander NC; Li X; Rouchka EC; Kirpich IA; Cave MC
    Toxicol Rep; 2021; 8():536-547. PubMed ID: 33777700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined exposure to polychlorinated biphenyls and high-fat diet modifies the global epitranscriptomic landscape in mouse liver.
    Klinge CM; Piell KM; Petri BJ; He L; Zhang X; Pan J; Rai SN; Andreeva K; Rouchka EC; Wahlang B; Beier JI; Cave MC
    Environ Epigenet; 2021; 7(1):dvab008. PubMed ID: 34548932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the mouse liver epitranscriptome by long-term aroclor 1260 exposure.
    Piell KM; Petri BJ; Head KZ; Wahlang B; Xu R; Zhang X; Pan J; Rai SN; de Silva K; Chariker JH; Rouchka EC; Tan M; Li Y; Cave MC; Klinge CM
    Environ Toxicol Pharmacol; 2023 Jun; 100():104138. PubMed ID: 37137421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.
    Wahlang B; Falkner KC; Gregory B; Ansert D; Young D; Conklin DJ; Bhatnagar A; McClain CJ; Cave M
    J Nutr Biochem; 2013 Sep; 24(9):1587-95. PubMed ID: 23618531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A compromised liver alters polychlorinated biphenyl-mediated toxicity.
    Wahlang B; Perkins JT; Petriello MC; Hoffman JB; Stromberg AJ; Hennig B
    Toxicology; 2017 Apr; 380():11-22. PubMed ID: 28163111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiomics Analysis of PCB126's Effect on a Mouse Chronic-Binge Alcohol Feeding Model.
    Gripshover TC; Wahlang B; Head KZ; Luo J; Bolatimi OE; Smith ML; Rouchka EC; Chariker JH; Xu J; Cai L; Cummins TD; Merchant ML; Zheng H; Kong M; Cave MC
    Environ Health Perspect; 2024 Apr; 132(4):47007. PubMed ID: 38619879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the effects of long-term Aroclor 1260 exposure on fatty liver disease in a diet-induced obesity mouse model.
    Head KZ; Bolatimi OE; Gripshover TC; Tan M; Li Y; Audam TN; Jones SP; Klinge CM; Cave MC; Wahlang B
    Front Gastroenterol (Lausanne); 2023; 2():. PubMed ID: 37426695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polychlorinated biphenyl exposures differentially regulate hepatic metabolism and pancreatic function: Implications for nonalcoholic steatohepatitis and diabetes.
    Shi H; Jan J; Hardesty JE; Falkner KC; Prough RA; Balamurugan AN; Mokshagundam SP; Chari ST; Cave MC
    Toxicol Appl Pharmacol; 2019 Jan; 363():22-33. PubMed ID: 30312631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL16-mediated translation of
    Tang J; Zhao X; Wei W; Liu W; Fan H; Liu XP; Li Y; Wang L; Guo J
    PeerJ; 2022; 10():e14379. PubMed ID: 36518278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease.
    Shi X; Wahlang B; Wei X; Yin X; Falkner KC; Prough RA; Kim SH; Mueller EG; McClain CJ; Cave M; Zhang X
    J Proteome Res; 2012 Jul; 11(7):3805-15. PubMed ID: 22686559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editor's Highlight: PCB126 Exposure Increases Risk for Peripheral Vascular Diseases in a Liver Injury Mouse Model.
    Wahlang B; Barney J; Thompson B; Wang C; Hamad OM; Hoffman JB; Petriello MC; Morris AJ; Hennig B
    Toxicol Sci; 2017 Dec; 160(2):256-267. PubMed ID: 28973532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic STAMP2 alleviates polychlorinated biphenyl-induced steatosis and hepatic iron overload in NAFLD models.
    Kim HY; Park CH; Park JB; Ko K; Lee MH; Chung J; Yoo YH
    Environ Toxicol; 2022 Sep; 37(9):2223-2234. PubMed ID: 35616167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of alternative splicing events related to fatty liver formation in duck using full-length transcripts.
    Wang Y; Song L; Ning M; Hu J; Cai H; Song W; Gong D; Liu L; Smith J; Li H; Huang Y
    BMC Genomics; 2023 Mar; 24(1):92. PubMed ID: 36858953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic Analysis Reveals Novel Mechanisms by Which Polychlorinated Biphenyls Compromise the Liver Promoting Diet-Induced Steatohepatitis.
    Hardesty JE; Wahlang B; Falkner KC; Shi H; Jin J; Zhou Y; Wilkey DW; Merchant ML; Watson CT; Feng W; Morris AJ; Hennig B; Prough RA; Cave MC
    J Proteome Res; 2019 Apr; 18(4):1582-1594. PubMed ID: 30807179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to 2,3,3',4,4',5-hexachlorobiphenyl promotes nonalcoholic fatty liver disease development in C57BL/6 mice.
    Shan Q; Chen N; Liu W; Qu F; Chen A
    Environ Pollut; 2020 Aug; 263(Pt A):114563. PubMed ID: 32304952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.